MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Utilizing Thrombectomy During PCI for STEMI
Current evidence, unresolved questions, and future trials.
By Tuncay Yetgin, MD; Michael Magro, MD; Robert-Jan Van Geuns, MD, PhD; and Felix Zijlstra, MD, PhD
Implantation Technique for Bioresorbable Scaffolds
Device description and patient/lesion selection with the Absorb BVS.
By Jiang Ming Fam, MD, MBBS, and Robert-Jan van Geuns, MD
Data Presented for Tryton's Side Branch System
May 25, 2010—Tryton Medical, Inc. (Durham, NC) announced results for the company's Tryton Side Branch stent system at a symposium during the EuroPCR 2010 conference in Paris.
Tryton Presents 6-Month Data for Its Side Branch System
Stentys Presents 4-Month Results from the APPOSITION IV Study
October 29, 2013—Stentys (Princeton, NJ) announced that results from the 4-month arm of the APPOSITION IV study of the company's new Self-Apposing sirolimus-eluting stent were presented by coprincipal investigator Robert Jan van Geuns, MD, at the TCT 2013: Transcatheter Cardiovascular Therapeutics conference in San Francisco, California.
IDEAL-LM Supports Shortened DAPT After PCI With Biodegradable-Polymer EES in Patients With Unprotected Left Main CAD
September 26, 2019—The Cardiovascular Research Foundation (CRF) announced that results from the IDEAL-LM study were presented by coprincipal investigator Prof.
PCI in Review: Guidelines and Practice
By Ted E. Feldman, MD, FSCAI, Chief Medical Editor
Stentys Expands APPOSITION III Enrollment to 1,000 AMI Patients
February 1, 2012—Stentys Inc. (Princeton, NJ) announced completion of expanded enrollment in the APPOSITION III clinical study of its self-apposing stent to treat acute myocardial infarction (AMI).
Stentys Presents Final Results from the APPOSITION IV Study
May 20, 2014—Stentys announced the presentation of final results from the APPOSITION IV study at the EuroPCR 2014 conference being held May 20–23 in Paris, France.
Current Trends in PCI
By Ted E. Feldman, MD, MSCAI, FACC, FESC
EuroPCR Session Examines Evidence for Bioresorbable Scaffolds
May 22, 2014—At the EuroPCR 2014 congress in Paris, France, a session was devoted to the development of evidence for bioresorbable vascular scaffolds, which represent a new era of vascular restoration in interventional cardiology. As summarized in the EuroPCR announcement, a panel of experts analyzed the available data and concluded that bioresorbable, fixed-strut vascular scaffolds are associated with increased acute thrombogenicity due to flow disturbances.
APPOSITION IV Data Published for the Stentys Self-Apposing Stent in STEMI Patients
February 15, 2016—Robert-Jan M. Van Geuns, MD, et al published results from the randomized APPOSITION IV trial in the online e-edition of EuroIntervention (2016;11:e1267–e1274).
